Long-Term Liabilities: The sum of all non-current liabilities.
Protagonist Therapeutics, Inc. (PTGX) had Long-Term Liabilities of $6.18M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$274.41M |
|
$220.01M |
|
$1.10M |
|
$273.31M |
|
$56.08M |
|
$218.33M |
|
$8.24M |
|
$226.57M |
|
$226.57M |
|
$220.01M |
|
$220.01M |
|
$220.01M |
|
$220.01M |
|
$218.33M |
|
$217.65M |
|
66.36M |
|
71.73M |
|
$3.32 |
|
$3.07 |
|
| Balance Sheet Financials | |
$1.10B |
|
$3.32M |
|
$45.49M |
|
$1.15B |
|
$55.46M |
|
-- |
|
|
Long-Term Liabilities |
$6.18M |
$61.64M |
|
$1.08B |
|
$1.08B |
|
$1.08B |
|
65.22M |
|
| Cash Flow Statement Financials | |
$146.89M |
|
$181.90M |
|
$41.12M |
|
$128.68M |
|
$498.58M |
|
$369.91M |
|
$42.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
99.60% |
|
79.56% |
|
79.56% |
|
-- |
|
82.57% |
|
80.18% |
|
$146.27M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
-- |
|
0.97 |
|
93.07 |
|
20.28% |
|
20.28% |
|
19.19% |
|
20.28% |
|
$16.64 |
|
$2.04 |
|
$2.05 |
|